- Intuitive Surgical is expected to report an EPS of $1.71, marking a 14% increase year-over-year.
- Projected revenues are set to reach approximately $2.19 billion, a 15.4% growth from the previous year.
- Analysts have revised the consensus EPS estimate upward by 0.2%, reflecting optimism about the company’s financial health.
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a leading company in the medical technology sector, known for its innovative robotic-assisted surgical systems. The company is set to release its quarterly earnings on April 22, 2025. Wall Street anticipates an earnings per share (EPS) of $1.71, with projected revenues of approximately $2.19 billion.
The expected EPS of $1.71 represents a 14% increase from the same period last year, as highlighted by the company’s strong performance. This growth is supported by a projected revenue increase of 15.4% year-over-year, reaching $2.18 billion. Such positive financial metrics indicate a robust demand for Intuitive Surgical’s products and services.
Over the past month, analysts have revised the consensus EPS estimate upward by 0.2%. This revision reflects a positive reassessment of the company’s financial health and potential, which can influence investor sentiment and the stock’s short-term price performance. Investors will closely watch the earnings release to see if the actual results align with these optimistic projections.
Intuitive Surgical’s stock performance is closely tied to its earnings results. A positive earnings surprise could lead to an increase in the stock price, while a miss might result in a decline. The management’s discussion during the earnings call will be crucial in evaluating the sustainability of any immediate price changes and future earnings projections.
The company’s financial ratios provide additional insights into its valuation. With a price-to-earnings (P/E) ratio of approximately 74.08, investors are willing to pay $74.08 for every dollar of earnings. The price-to-sales ratio stands at about 20.71, and the enterprise value to sales ratio is around 20.47. These figures reflect the company’s valuation in relation to its sales and earnings. Additionally, Intuitive Surgical has a strong current ratio of 4.07, indicating its ability to cover short-term liabilities with its short-term assets.
